Last reviewed · How we verify
COVID-19
Approved treatments
- CILGAVIMAB · AstraZeneca
- Evusheld · AstraZeneca
- Regkirona · Celltrion Healthcare Hungary Kft.
- Vaccine Support Cp · Women and Infants Hospital of Rhode Island
- Paxlovid (Copackaged) · Pfizer
Nirmatrelvir inhibits SARS-CoV-2 main protease; ritonavir inhibits CYP3A-mediated metabolism of nirmatrelvir. - Paxlovid (Copackaged) · Pfizer
Paxlovid works by inhibiting the activity of an enzyme that the SARS-CoV-2 virus needs to replicate. - IMDEVIMAB · Regeneron Pharmaceuticals, Inc.
IMDEVIMAB works by binding to the SARS-CoV-2 virus to prevent it from entering host cells. - ibuzatrelvir · Pfizer
- Norvir · AbbVie
Norvir works by blocking the cytochrome P450 3A enzyme, which helps increase the levels of other medications in the body. - Low Dose PF-07328948 · Pfizer
- Paxlovid (Copackaged) · Pfizer
Paxlovid works by inhibiting the activity of the SARS-CoV-2 protease enzyme, which is essential for the virus's replication. - Paxlovid (Copackaged) · Pfizer
Paxlovid works by binding to the main protease enzyme of the SARS-CoV-2 virus, preventing it from replicating. - Medium Dose PF-07328948 · Pfizer
- Ronapreve · Regeneron Pharmaceuticals, Inc.
- Beta-D-N4-Hydroxycytidine · Msd K.K.
Molnupiravir works by introducing errors into the genetic material of the SARS-CoV-2 virus, preventing it from replicating. - Ly-Cov555 · Eli Lilly and Company
Ly-Cov555 works by binding to the SARS-CoV-2 virus and preventing it from entering host cells. - Ly-Cov016 · Eli Lilly and Company
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- High Dose PF-07328948 · Pfizer
- Norvir · Saint Michael's Medical Center
Pipeline
- Raxtozinameran 12 years of age and older · Pfizer Inc. — preclinical
Clinical guidelines
- FDA label — 1L
PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Hepatitis A. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Hepatitis B. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Meningococcal disease. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of COVID-19. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Influenza. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Pneumococcal disease. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Rotavirus infection. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Varicella (chickenpox). - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Measles, Mumps, and Rubella. - FDA label — 1L
Vaccine Support Cp is indicated for the prevention of Human Papillomavirus infection.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape: